ALEXIS Biochemicals: MEDICA 16

ALX-340-039

Revised 05-Feb-05

MEDICA 16
SYNONYMS	3,3,14,14-Tetramethylhexadecanedioic acid
PRODUCT LINE	Obesity & Adipokines
PRODUCT CATEGORY	Cholesterol & Lipid Transport / Related Products

Ordering Information

Product Numbers:	Format:	Size:	Unit Price:	Quantity:	Add To Cart
ALX-340-039-M005		5 mg	92.00 USD

Product Specification

FORMULA:	C₂₀H₃₈O₄
MW:	342.5
CAS NUMBER:	87272-20-6
PURITY:	≥98%
APPEARANCE:	Crystalline solid.
SOLUBILITY:	100mg/ml soluble in DMSO, dimethyl formamide or 100% ethanol. Slightly soluble in aqueous buffers.
SHIPPING:	SHIPPED ON BLUE ICE
LONG TERM STORAGE:	-20°C

Product Description

Hypolipidemic and antidiabetic agent, shown to reduce adiposity. Induces malic enzyme, mitochondrial glycerol-3-phosphate dehydrogenase, and carnitine palmitoyl transferase I. Inhibitor of citrate lyase and acetyl-CoA carboxylase, expected to disinhibit hepatic fatty acid oxidation while up-regulating electron shuttle mechanism, and thus should stimulate reverse electron transport. Exhibits thyromimetic properties with respect to the modulation of rat liver redox and phosphate potentials.

Product Specific Literature References

Inhibition of lipid synthesis by beta beta'-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo: J. Bar-Tana, et al.; J. Biol. Chem. 260, 8404 (1985) Abstract; Full Text
The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III: B. Frenkel, et al.; J. Biol. Chem. 263, 8491 (1988) Abstract; Full Text
Adipose reduction by beta,beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16): R. Tzur, et al.; Int. J. Obes. 13, 313 (1989), Review Abstract
Inhibition of rat liver acetyl-CoA carboxylase by beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16): G. Rose-Kahn & J. Bar-Tana; Biochim. Biophys. Acta 1042, 259 (1990) Abstract
Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats: J.C. Russell, et al.; Arterioscler. Thromb. 11, 602 (1991) Abstract
Tissue selective modulation of redox and phosphate potentials by beta,beta'-methyl-substituted hexadecanedioic acid: B. Kalderon, et al.; Endocrinology 131, 1629 (1992) Abstract
Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III: R. Hertz, et al.; J. Biol. Chem. 270, 13470 (1995) Abstract; Full Text
Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo: N. Mayorek, et al.; Diabetes 46, 1958 (1997) Abstract
Mitochondria uncoupling by a long chain fatty acyl analogue: O. Hermesh, et al.; J. Biol. Chem. 273, 3937 (1998) Abstract; Full Text
Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16: J.C. Russell, et al.; Diabetes 47, 770 (1998) Abstract; Full Text
Peroxisome proliferators as adjuvants for the reverse-electron-transport therapy of obesity: an explanation for the large increase in metabolic rate of MEDICA 16-treated rats: M.F. McCarty; Med. Hypotheses 53, 272 (1999) Abstract
Mitochondrial protonophoric activity induced by a thyromimetic fatty acid analogue: O. Hermesh, et al.; Biochim. Biophys. Acta 1457, 166 (2000) Abstract
Fatty acid cycling in the fasting rat: B. Kalderon, et al.; Am. J. Physiol. Endocrinol. Metab. 279, E221 (2000) Abstract; Full Text
MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats: L.L. Atkinson, et al.; Diabetes 51, 1548 (2002) Abstract
Genotoxicity of streptozotocin: A.D. Bolzan and M.S. Bianchi; Mutat. Res. 512, 121 (2002), (Review) Abstract

Further Categories Containing This Product:

Antidiabetic Agents / Related Products

another CS2 website

Online Product Ordering

Clipboard [0]

Your items will be kept only for the duration of your visit.